SELLERS ROBERT W.A. 4
4 · Edwards Lifesciences Corp · Filed Apr 28, 2023
Insider Transaction Report
Form 4
SELLERS ROBERT W.A.
VP, Corporate Controller
Transactions
- Exercise/Conversion
Common Stock
2023-04-28$35.20/sh+12,270$431,864→ 24,019.79 total - Sale
Common Stock
2023-04-28$87.20/sh−12,270$1,069,944→ 11,749.79 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2023-04-28−12,270→ 0 totalExercise: $35.20From: 2017-05-12Exp: 2023-05-11→ Common Stock (12,270 underlying)
Holdings
- 20,409(indirect: By Trust)
Common Stock